AI Article Synopsis
- Immunotherapy is gaining attention as a cancer treatment option due to its potential to tackle issues like tumor escape and immunosuppression.
- The use of chimeric antigen receptor (CAR) T cells has seen success in blood cancers, but their effectiveness in solid tumors remains limited.
- The review highlights the latest advancements in CAR T cell therapy while addressing existing challenges and opportunities for improvement.
Article Abstract
The use of immunotherapy as an alternative treatment for cancer patients has become of great interest in the scientific community as it is required to overcome many of the currently unsolved problems such as tumor escape, immunosuppression and unwanted unspecific toxicity. The use of chimeric antigen receptor T cells has been a very successful strategy in some hematologic malignancies. However, the application of CAR T cells has been limited to solid tumors, and this has aimed the development of new generation of CARs with enhanced effectivity and specificity. Here, we review the state of the art of CAR T cell therapy with special emphasis on the current challenges and opportunities.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/978-1-0716-0759-6_14 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!